PMID: 15243868Jul 10, 2004Paper

Leukotriene modifiers in asthma management

IDrugs : the Investigational Drugs Journal
Valérie Capra, G Enrico Rovati

Abstract

The prevalence of asthma is increasing, especially among children. Despite the attention focused on the acute phase of asthma, asthmatic airways demonstrate increased inflammatory cell infiltration and irreversible structural alterations (remodeling). Thus, therapy must transcend the control of symptoms and focus on the prevention of chronic inflammation, which progressively evolves toward airway remodeling. Leukotrienes have been demonstrated to play a causative role both in the early bronchoconstriction noted in asthmatics and in the late chronic inflammatory component, and drugs that can inhibit the actions or synthesis of leukotrienes (leukotriene modifiers) are now available by prescription.

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Expert Review of Respiratory Medicine
Kanami OriharaRedwan Moqbel
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
Stephen R Dager
© 2022 Meta ULC. All rights reserved